Our work
It is very common to find gaps in physico-chemical and (eco)toxicological data sets, which preclude confident hazard and risk assessment. Testing on vertebrate animals has ethical concerns across all sectors, and is banned for cosmetics marketed in Europe. Laboratory animal studies are in any case often undesirable for more mundane reasons such as time and costs. Where possible, we strive to help clients fill data gaps without a potentially costly and animal-intensive trip to the testing laboratory.
Computer models have been developed to predict the toxicological characteristics of an untested compound based on knowledge of the activity of others. (Q)SAR modelling is gaining regulatory acceptance. Indeed, in some sectors (Q)SAR analysis is a requirement. It can also be used as a screening exercise to inform a company on whether laboratory testing is scientifically justified.
Interpretation
Our vast experience in applying these toxicity models is matched by our expertise in interpreting the results. The limitations of (Q)SAR models must be understood and described, and the results should be applied appropriately. (Q)SAR results should always be interpreted in the context of any literature identified in searches of databases such as bibra’s own TRACE. Our toxicologists perform robust sanity checks on all of the outputs to ensure that predictions are sensible and consistent with our on-the-job knowledge and expectations.
Expertise/Leadscope
Bibra is an expert consulting partner of Leadscope, which we use frequently in-house, including for the evaluation of DNA-reactive compounds (particularly pharmaceutical impurities), in accordance with ICH guidance M7. Toxicology Director, Pete Watts and Senior Toxicologist, Chris Waine, are regular contributors to Leadscope’s continuing development through participation in working groups, and have been involved in several publications in the peer-reviewed literature.
Models
Our in-house team and expert partners can generate (Q)SAR predictions using a range of in silico models, including:
Helpful links
In silico toxicology protocols
Myatt et al. 2018: Regulatory Toxicology and Pharmacology (volume 96)
Genetic toxicology in silico protocol
Hasselgren et al. 2019: Regulatory Toxicology and Pharmacology (volume 107)
Some of our case studies in this area
A human health risk assessment of API-related impurities
Case study
Whilst developing an inhalation spray drug product, the client identified two impurities with chemical structures related to the Active Pharmaceutical Ingredient (API). Click through to read more about how we dealt with this interesting project.
Determining a Specific Migration Limit (SML) for a data-deficient compound identified in food labels
Case study
The client was informed by a supplier that a chemical compound with a worrying structure was present within a food label ink. Click to find out how we dealt with it.
Exploring Alternative Methods to Animal Toxicity Testing
Blog articles
It has been promised for a heck of a long time, but are we now close to an era when a chemical’s toxic potential can be comprehensively defined without exploiting fellow sentient creatures. As well as this obvious ethical gain, alternative test methods to animal testing have the equally attractive potential to reduce the times and costs associated with safety testing.